Your browser doesn't support javascript.
loading
Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease.
Galactionova, Katya; Salari, Paola; Mattli, Renato; Rachamin, Yael; Meier, Rahel; Schwenkglenks, Matthias.
Afiliação
  • Galactionova K; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland.
  • Salari P; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland.
  • Mattli R; Winterthur Institute of Health Economics, Zurich University of Applied Sciences, Winterthur, Switzerland.
  • Rachamin Y; Institute of Primary Care, University of Zurich, Zurich, Switzerland.
  • Meier R; University Hospital Zurich, Zurich, Switzerland.
  • Schwenkglenks M; Institute of Primary Care, University of Zurich, Zurich, Switzerland.
Pharmacoeconomics ; 40(8): 791-806, 2022 08.
Article em En | MEDLINE | ID: mdl-35723806
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article